Journal of Alzheimer's & Dementia Open Access

Dr. Leandro Bueno Bergantin

Biography

Dr. Bergantin received his academic education at EPM-UNIFESP (Brazil) and UAM (Spain): degree in biomedicine (2008), MSc (2010) and PhD (2014). His research involves neuropsychopharmacology, autonomic and cardiovascular pharmacology, cell signaling mediated by Ca2+ and cAMP. His research work solved the enigma of the paradoxical effects produced by L-type Ca2+ channel blockers (TOP 25 Hottest Articles - Biochemistry, Genetics and Molecular Biology - Cell Calcium - TOP 1 July to September 2013/ TOP 5 October to December 2013/ TOP 1 January to December 2013 full year/TOP 6 January to March 2014). PhD (Pharmacology). Federal University of São Paulo, UNIFESP, Brazil. with sandwich period in Universidad Autónoma de Madrid - Spain Title: Novel model for ?calcium paradox? in sympathetic transmission of smooth muscles: role of cAMP pathway, Year: 2014. Fellow by: Conselho Nacional de Desenvolvimento Científico e Tecnológico, CNPq, Brazil. MSc (Pharmacology). Federal University of São Paulo, UNIFESP, Brazil. Title: Novel in situ system to evaluate skeletal muscle proteolysis: role of cAMP pathway, Year: 2010. Fellow by: Fundação de Amparo à Pesquisa do Estado de São Paulo, FAPESP, Brazil. BSc (Biomedicine). Federal University of São Paulo, UNIFESP, Brazil. Title: Effects of chronic denervation on adenylyl cyclase activity of skeletal muscles, Year: 2008 Fellow by: Conselho Nacional de Desenvolvimento Científico e Tecnológico, CNPq, Brazil. Technician (Quality and Productivity). University of Campinas, UNICAMP, Brazil. Year: 2003 Postdoctoral 2015 Postdoctoral. Federal University of São Paulo, UNIFESP, Brazil. Fellow by: Fundação de Amparo à Pesquisa do Estado de São Paulo, FAPESP, Brazil.

Research Interest

His research work solved the enigma of the paradoxical effects produced by L-type Ca2+ channel blockers (TOP 25 Hottest Articles - Biochemistry, Genetics and Molecular Biology - Cell Calcium - TOP 1 July to September 2013/ TOP 5 October to December 2013/ TOP 1 January to December 2013 full year/TOP 6 January to March 2014).